Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
XW Labs Initiates First-in-Human Phase I Study for Novel Narcolepsy Treatment
2018-03-12 17:00
EpiVax and GAIA Vaccine Foundation Celebrate Women's Achievements Throughout History and Across Nations
2018-03-09 01:25
JW Therapeutics Closes $90 Million Series A Financing
2018-03-08 11:05
Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Stroke Recovery
2018-03-05 22:00
WuXi Biologics Announces Positive Profit Alert
2018-03-05 17:48
CARsgen Completed $60 Million Pre-C Financing Framework Agreements
2018-03-02 14:00
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2017
2018-03-01 06:00
WuXi Biologics Congratulates MabSpace on FDA Clearance of IND for MSB2311
2018-02-27 08:04
The US FDA Granted Orphan Drug Designation to Yisheng Biopharma's Biological Product for Pancreatic Cancer Treatment
2018-02-26 22:00
TWi Biotechnology, Inc. Announced Regulatory Clearance to Begin Phase 2 Proof-of-Concept Clinical trial of AC-203 for treatment of Inherited Epidermolysis Bullosa
2018-02-26 16:58
China Biologic Products to Report Fourth Quarter and Fiscal Year 2017 Financial Results
2018-02-23 21:00
WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration
2018-02-22 15:23
Biostar Pharmaceuticals, Inc. Announces Plans to Launch a New eCommerce Sales Platform
2018-02-21 22:00
China Biologic to Build New Collection Station in Hainan Province
2018-02-14 21:30
WuXi Biologics Congratulates Tychan for Dosing First Patient of a Zika Antibody after Record 9 Months of Development
2018-02-09 09:04
Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification
2018-02-07 22:00
GC Pharma Reports Full Year 2017 Results
2018-02-05 10:46
/DISREGARD RELEASE: ACT Genomics/
2018-02-02 19:43
WuXi Biologics and Aravive Biologics to Form Strategic Manufacturing Collaboration Following Successful IND Filing for AVB-S6-500
2018-01-30 09:00
WuXi Biologics Announces Formation of Scientific Advisory Board
2018-01-24 17:05
1
141
142
143
144
145
165